Sanguine Media Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2026 ,inter alia, to consider and approve Audited Results
Awaiting price reaction for this filing.
Sanguine Media Ltd has informed BSE that its Board meeting scheduled for May 29, 2026 to consider and approve the Audited Financial Results for Q4 and the financial year ended March 31, 2026 was extended across two days. The meeting commenced on May 29 and continued till 8:30 PM, then reconvened on May 30 from 11:00 AM till 6:35 PM. However, the Board could not conclude the agenda due to pending discussions and the need for further consideration of financial statements. The meeting has been adjourned and rescheduled to June 9, 2026 to finalize the results approval.
The adjournment of the Board meeting, with deliberations spanning nearly two full days, suggests complex or potentially sensitive financial matters under discussion. Investors should await the official outcome on June 9, 2026, as the delayed approval raises uncertainty about the nature of the pending issues.